# Constraining string cosmology with the gravitational-wave background using the NANOGrav 15-year data set

Preprint · Qin Tan, You Wu, Lang Liu

- Archive id: arxiv:2409.17846
- Published: 2024-09-26
- Venue: Eur.Phys.J.C 85 (2025) 3, 327
- DOI: https://doi.org/10.1140/epjc/s10052-025-13998-1
- arXiv: https://arxiv.org/abs/2409.17846
- Source URL: https://arxiv.org/abs/2409.17846
- PDF: https://arxiv.org/pdf/2409.17846
- Provenance: arxiv

## Abstract

The North American Nanohertz Observatory for Gravitational Waves (NANOGrav) collaboration has recently reported strong evidence for a signal at nanohertz, potentially the first detection of the stochastic gravitational-wave background (SGWB). We investigate whether the NANOGrav signal is consistent with the SGWB predicted by string cosmology models. By performing Bayesian parameter estimation on the NANOGrav 15-year data set, we constrain the key parameters of a string cosmology model: the frequency $f\_s$ and the fractional energy density $Ω\_\\mathrm{gw}^{s}$ of gravitational waves at the end of the dilaton-driven stage, and the Hubble parameter $H\_r$ at the end of the string phase. Our analysis yields constraints of $f\_s = 1.2^{+0.6}\_{-0.6}\\times 10^{-8} \\mathrm{Hz}$ and $Ω\_\\mathrm{gw}^{s} = 2.9^{+5.4}\_{-2.3}\\times 10^{-8}$, consistent with theoretical predictions from string cosmology. However, the current NANOGrav data is not sensitive to the $H\_r$ parameter. We also compare the string cosmology model to a simple power-law model using Bayesian model selection, finding a Bayes factor of $2.2$ in favor of the string cosmology model. Our results demonstrate the potential of pulsar timing arrays to constrain cosmological models and study the early Universe.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.